Delivery Order 36F79721D0249-36C24826F0207
Award Date 7/29/26
Potential Completion Date 7/31/26
Potential Value $184K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
King of Prussia, PA 19406, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a $145,345.90 delivery order to CSL Behring L.L.C. under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The order is for HAEGARDA C1 inhibitor (human) 3000 units vials, with a completion date of November 15, 2021. The pricing is firm fixed price and there was no set-aside designation applied. The place of performance is King of Prussia, Pennsylvania, and the award...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VA - VHA) awarded CSL Behring L.L.C. a $380,625.84 delivery order under the company's Pharmaceuticals and Drugs (FSS-61-IB) master contract on the General Services Administration (GSA) Multiple Award Schedule. The order is for HAEGARDA C1 INHIBITORS 3000 UNITS to be provided from CSL Behring L.L.C.'s place of performance in King of Prussia, Pennsylvania under firm fixed pricing from October...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a $153,924.40 delivery order to CSL Behring L.L.C. under the Pharmaceuticals and Drugs Federal Supply Schedule master contract. The order is for 3,000 units of HAEGARDA C1 Inhibitors (Human) to be delivered to a location in King of Prussia, Pennsylvania by June 3, 2022. The contract has a firm fixed price and no set-aside designation was used. This delivery order will provide a...
- The Department of Veterans Affairs Veterans Health Administration awarded a $113,280 delivery order against the CSL Behring L.L.C. Pharmaceuticals and Drugs GSA Schedule to provide HAEGARDA injections for Veterans Integrated Service Network 7. CSL Behring will deliver the medication from its facility in King of Prussia, Pennsylvania to locations within VISN 7 over a three-month period concluding September 30, 2023. The firm fixed price order was awarded without any set aside designations to...
- CSL Behring L.L.C. was awarded a $35,182.72 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9. This firm fixed price order is for 3,000 units of HAEGARDA injection to be delivered to a location in King of Prussia, Pennsylvania by January 28, 2022. The FSS contract functions as a large purchasing vehicle managed by the General Services...
- The Department of Veterans Affairs Veterans Health Administration (VA) awarded a $103,256.12 firm fixed price delivery order to CSL Behring L.L.C. for the supply of HAEGARDA, a C1 inhibitor (human) injection solution, to the VA's Veterans Integrated Service Network 8. This order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract with the General Services Administration and the VA. The order has a completion date of December 31, 2018 and did not have...
- This is a delivery order awarded by the Veterans Integrated Service Network 8 (VISN 8), a division of the U.S. Department of Veterans Affairs (VA), to CSL Behring L.L.C. for the supply of 72 units of the pharmaceutical product HAEGARDA (a C1 inhibitor for hereditary angioedema). The contract has a firm fixed price of $87,207.54 and an ultimate completion date of April 28, 2021. This delivery order was placed against CSL Behring's primary Federal Supply Schedule contract for Pharmaceuticals and...
- CSL Behring L.L.C. was awarded a $103,831.50 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7. The order is for the delivery of HAEGARDA 2000 INJ/VIALS AND HAEGARDA 3000 INJ/VIALS to an address in King of Prussia, Pennsylvania, with work to be completed by March 31, 2022. No set-aside designation was applied to this order. CSL Behring L.L.C. will...
- CSL Behring L.L.C. was awarded a $58,635.84 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19. The firm fixed price order is for the delivery of HAEGARDA vials to the place of performance in King of Prussia, Pennsylvania, with completion scheduled for June 19, 2022. No set-aside designation was applied to this order, which was awarded on June 14, 2022...
- CSL Behring L.L.C. was awarded a one hundred thirteen thousand two hundred eighty dollar ($113,280) delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7. The firm fixed price order has a completion date of March 31, 2023 and was awarded on January 1, 2023 to provide HAEGARDA pharmaceuticals with no set-aside designation applied. The delivery order was...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79721D0249Federal Supply Schedule
- 36F79721D0249-36C24826F0207Delivery Order
Veterans Integrated Service Network 8 issued a $183,902.60 delivery order to CSL Behring L.L.C. on July 29, 2026, for 3,000 units per vial of HAEGARDA (C1 inhibitor injection solution) under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB). The order is issued under GSA's multiple-award Federal Supply Schedule for pharmaceuticals and drugs, with a parent ceiling of $201.48 million valid through September 29, 2026. Place of performance is King of Prussia, Pennsylvania, where CSL Behring manufactures and distributes the product. Ultimate completion date is July 31, 2026. Pricing is firm fixed price with no set-aside designation.
Generated 7/30/26, 11:08 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $183.9k | 7/28/26 |